iBio, Inc.
IBIO US4510336096
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Duran Felipe CFO |
2.72 USD |
9,191 Bought |
25,000 USD |
10/01/2025 | 10/01/2025 |
Brenner Martin O |
2.72 USD |
9,191 Bought |
25,000 USD |
10/01/2025 | 10/01/2025 |
Parada Antonio Bernardino Guimaraes O |
2.72 USD |
183,823 Bought |
499,999 USD |
10/01/2025 | 10/01/2025 |
Arkowitz David O |
2.72 USD |
18,382 Bought |
49,999 USD |
10/01/2025 | 10/01/2025 |
Sender Gary O |
2.72 USD |
9,191 Bought |
25,000 USD |
10/01/2025 | 10/01/2025 |
Banjak Marc CLO |
2.72 USD |
9,191 Bought |
25,000 USD |
10/01/2025 | 10/01/2025 |
Clark William D O |
2.72 USD |
1,838 Bought |
4,999 USD |
10/01/2025 | 10/01/2025 |
Brenner Martin O |
0.27 USD |
4,881 Sold |
1,296 USD |
01/11/2023 | 01/11/2023 |